Prospective Anti-Hepatitis C Virus (Anti-HCV) Trial of Peg-Interferon and Ribavirin in Subjects of First Nations, Metis and Caucasian Ethnicity

NCT00957866 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Pegylated Interferons (Peg-IFN) and Ribavirin

Sponsor

University of Manitoba

Collaborators

[object Object]